Back to search

University of Patras

Μελέτη των νευροδιαβιβαστικών συστημάτων της ντοπαμίνης και του γλουταμινικού οξέος στο κεντρικό νευρικό σύστημα πειραματικών μοντέλων ...

Abstract

dc:description

Basal ganglia are subcortical structures comprising several interconnected nuclei in the brain and particularly the striatum, globus pallidus, substantia nigra (SN), and subthalamic nucleus. The neural pathway that connects the substantia nigra with the striatum is one of the major dopamine pathways in the brain, and is involved in the control of movement. In the present thesis we examined the dopaminergic and glutamatergic neurotransmission systems of basal ganglia, using two different animal models. The first goal of the thesis was to investigate whether TrkA gene transfer into SN neurons of adult rats influence some of their neurochemical properties, in the absence or presence of exogenous nerve growth factor (NGF) delivery in the striatum. It is well known that neurotrophic factors are proteins which promote neuronal survival, participate in axonal growth and influence axonal targeting to establish contacts during development. In adulthood, neurotrophic factors are required to maintain neuronal functions and specific neuronal phenotype. NGF exerts its neurotrophic effects through its high affinity receptor, TrkA, which is a membrane tyrosine-kinase. In the present study, a recombinant adeno-associated virus AAV-CMV-TrkA was injected in the right substantia nigra pars compacta (SNpc) and a AAV-CBA-NGF in the ipsilateral striatum. The effects of ectopic TrkA expression on locomotor activity of the animals were assessed using the open field and rotarod tests. The expression of TrkA and NGF transgenes in SNpc and striatum, respectively, was detected by immunohistochemistry. Additionally, the effects of ectopic TrkA expression on the dopaminergic traits of nigrostriatal neurons were assessed by measuring mRNA and protein levels of the tyrosine-hydroxylase (TH), dopamine transporter (DAT), D1 and D2 dopamine (DA) receptors. The presence of TrkA transgene in SN resulted in a significant decrease of TH immunoreactivity, TH mRNA and DAT mRNA expression in the right SN compared to the contralateral side, while no difference was found in the mRNA expression of D2 DA receptors and [3H]raclopride binding in SN. No significant changes were seen in the density of DAT by measuring [3H]WIN35428 binding sites and DAT immunoreactivity in the ipsilateral striatum, as well as in the number of postsynaptic striatal D1 and D2 receptor binding sites, as determined by [3H]SCH23390 and [3H]raclopride, respectively. The glutamatergic receptors NMDA and AMPA in SN and striatum, and the GABAergic receptors GABAA in striatum were assessed by measuring mRNA levels of the GluRB subunit of AMPA receptors, [3H]AMPA binding, [3H]MK-801 binding for NMDA receptors and [3H]SR95531 for GABAA receptors. No significant changes were found in NMDA and AMPA receptors. The presence of exogenous NGF in the striatum resulted in an increase of GABAA receptors in the ipsilateral compared to the contralateral striatum. These data suggest that ectopic TrkA expression in SN downregulates tyrosine hydroxylase in nigral dopaminergic neurons, while the dopamine signaling is not affected in the striatum. Furthermore, these data suggest that ectopic TrkA expression has no significant neurotoxicity in SN or striatum, and most importantly TrkA elicits NGF-independent responses. The second goal of the present thesis was to examine the dopaminergic system of basal ganglia in a mouse model of DYT1 dystonia. Early-onset DYT1 dystonia is an autosomal dominant movement disorder caused by a 3-base pair deletion (GAG) in the DYT1 gene resulting in the loss of a glutamic acid residue in the torsinA protein. Symptoms of this disorder typically develop before the age of 21 years and include involuntary sustained muscle contractions. There are data supporting the hypothesis that basal ganglia dysfunction, and specifically dopaminergic system dysfunction, plays a role in dystonia. In the present study, we used hyperkinetic transgenic mice generated as a model of DYT1 dystonia and compared the basal ganglia dopaminergic system between transgenic mice exhibiting hyperkinesia (affected), transgenic mice not showing movement abnormalities (unaffected), and non-transgenic littermates. A decrease in the density of striatal D2 binding sites, measured by [3H]raclopride binding, and D2 mRNA expression in substantia nigra pars compacta (SNpc) was revealed in affected and unaffected transgenic mice when compared with non-transgenic. No difference in D1 receptor binding and DAT binding, measured by [3H]SCH23390 and [3H]WIN35428 binding, respectively, was found in striatum of transgenic animals. In SNpc, increased levels of DAT binding sites were observed in affected and unaffected animals compared to non-transgenic, whereas no change in DAT mRNA expression was found. These data indicate neurochemical changes in the basal ganglia dopaminergic system and suggest a possible involvement of dopamine neurotransmission in the pathophysiology of dystonia-like motor hyperactivity.

Degree

thesis:*
Grantor dc:publisher
University of Patras
Year dc:date
2010

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Γιαννακοπούλου, Δήμητρα
  • Giannakopoulou, Dimitra

Subjects

dc:subject × 19

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/27733

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Γιαννακοπούλου, Δήμητρα; Giannakopoulou, Dimitra. Μελέτη των νευροδιαβιβαστικών συστημάτων της ντοπαμίνης και του γλουταμινικού οξέος στο κεντρικό νευρικό σύστημα πειραματικών μοντέλων .... University of Patras, 2010. http://hdl.handle.net/10442/hedi/27733